Alpa Laboratories balance sheet

As of Mar 2026

Total assets: ₹242cr+8.8% on Mar 2025
Shareholders' equity: ₹186cr+8.7% on Mar 2025
Total debt: ₹2.5crNo figure a year before
Cash and investments: ₹136cr+22.8% on Mar 2025

₹ crore except per share

Tap a line for its trend	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

Current assets
Non-current assets					FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	20.1	20.6	11.4	7.0
	0.0	0.0	0.0	0.0
	0.0	0.0	0.1	0.1
	6.6	7.4	6.9	6.4
	4.5	3.4	3.0	1.9
	11.1	10.8	9.9	8.3
	31.2	31.4	21.4	15.4
	13.3	17.6	13.7	12.6
	135	110	91.1	72.0
	40.8	46.8	41.4	46.7
	0.6	0.0	0.1	8.8
	2.2	2.2	1.6	1.3
	0.5	0.5	0.6	0.6
	2.9	1.3	1.8	1.8
	182	161	137	131
	12.5	8.9	9.0	8.2
	211	191	161	152
	242	223	183	167
Equity
	21.0	21.0	21.0	21.0
	165	150	131	114
	186	171	152	135
	186	171	152	135
Liabilities
	0.0	0.0	0.0	2.3
	0.0	0.0	0.0	2.3
	3.3	4.5	2.4	0.0
	3.3	4.5	2.4	2.3
	2.5	0.0	5.2	0.0
	17.8	18.7	11.8	15.1
	1.3	1.1	1.1	0.5
	21.6	19.7	18.1	15.6
	6.4	5.6	2.4	3.7
	24.5	21.4	7.8	2.3
	52.5	46.7	28.3	30.6
	55.9	51.2	30.7	32.9
	242	223	183	167
Assets — additional as-filed lines
	2.9	3.3	1.9	0.0
Liabilities — additional as-filed lines
	—	0.0	0.0	9.0
Trade payables — MSME split
	4.3	1.5	—	—
	13.5	17.2	—	—

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

ALPA₹52.20

Alpa Laboratories Limited

· Pharma & Health

₹ CrorePeersBALPHARMA KREBSBIO NATCAPSUQ VINEETLAB NECLIFE AAREYDRUGS BIOFILCHEM MANGALAMMcap ₹110 Cr

View

In ₹ Crore except Per Share As of	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Non-current Assets
+ Property, Plant & Equipment	7.0	11.4	20.6	20.1	20.1
+ Other Intangibles	0.0	0.0	0.0	0.0	0.0
+ Intangibles under Development	0.1	0.1	0.0	0.0	0.0
+ Non-current Investments	6.4	6.9	7.4	6.6	6.6
+ Other Non-current Financial Assets	1.9	3.0	3.4	4.5	4.5
Non-current Financial Assets	8.3	9.9	10.8	11.1	11.1
Total Non-current Assets	15.4	21.4	31.4	31.2	31.2
Current Assets
+ Inventories	12.6	13.7	17.6	13.3	13.3
+ Current Investments	72.0	91.1	110.5	135.0	135.0
+ Trade Receivables	46.7	41.4	46.8	40.8	40.8
+ Cash & Cash Equivalents	8.8	0.1	0.0	0.6	0.6
+ Other Bank Balances	1.3	1.6	2.2	2.2	2.2
+ Short-term Loans	0.6	0.6	0.5	0.5	0.5
+ Other Current Financial Assets	1.8	1.8	1.3	2.9	2.9
Current Financial Assets	131.3	136.7	161.3	182.2	182.2
+ Other Current Assets	8.2	9.0	8.9	12.5	12.5
Total Current Assets	152.1	161.2	191.2	210.9	210.9
Total Assets	167.5	182.6	222.6	242.1	242.1
Equity
+ Equity Share Capital	21.0	21.0	21.0	21.0	21.0
+ Other Equity / Reserves	113.5	130.9	150.4	165.2	165.2
Equity — Owners of Parent	134.6	151.9	171.4	186.3	186.3
Total Equity	134.6	151.9	171.4	186.3	186.3
Liabilities
+ Borrowings — Non-current	2.3	0.0	0.0	0.0	0.0
Non-current Financial Liabilities	2.3	0.0	0.0	0.0	0.0
+ Deferred Tax Liabilities	0.0	2.4	4.5	3.3	3.3
Non-current Liabilities	2.3	2.4	4.5	3.3	3.3
+ Borrowings — Current	0.0	5.2	0.0	2.5	2.5
+ Trade Payables	15.1	11.8	18.7	17.8	17.8
+ Other Current Financial Liab	0.5	1.1	1.1	1.3	1.3
Current Financial Liabilities	15.6	18.1	19.7	21.6	21.6
+ Provisions — Current	3.7	2.4	5.6	6.4	6.4
+ Other Current Liabilities	2.3	7.8	21.4	24.5	24.5
Current Liabilities	30.6	28.3	46.7	52.5	52.5
Total Liabilities	32.9	30.7	51.2	55.9	55.9
Total Equity & Liabilities	167.5	182.6	222.6	242.1	242.1
Assets — additional as-filed lines
+ Current Tax Assets	0.0	1.9	3.3	2.9	2.9
Liabilities — additional as-filed lines
+ Deferred Government Grants — Current	9.0	0.0	0.0	—	—
Trade Payables — MSME split
+ Dues to Micro & Small — Current	—	—	1.5	4.3	4.3
+ Dues to Other Creditors — Current	—	—	17.2	13.5	13.5

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.